Publikacje w NEJM, JAMA i Lancet
z udziałem pracowników IK w latach 2005-2016

  1. 1. Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L, APPRAISE-2 Investigators.: Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med. 2011; 365(8): 699-708. IF=53.298; MNiSW=40

  2. 2. John H Alexander, U. Andersson, RD. Lopes, Z. Hijazi, SH. Hohnloser, JA. Ezekowitz, S. Halvorsen, M. Hanna, P. Commerford, Witold Rużyłło, K. Huber, SM. Al-Khatib, CB. Granger, L. Wallentin: Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiology, 2016, 1 (6) 673-681,
    brak punktów

  3. 3. Antman EM, Morrow DA, McCabe CH, Murphy SA, Ruda M, Sadowski Z, Budaj A, Lopez-Sendon JL, Guneri S, Jiang F, White HD, Fox KA, Braunwald E, ExTRACT-TIMI 25 Investigators.: Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med. 2006; 354(14): 1477-1488.
    IF=51.296; MNiSW=30

  4. 4. F Castinetti, XP Qi, MK Walz, AL. Maia, G Sanso, Mariola Pęczkowska, K. Hasse-Lazar, TP Links, S. Dvorakova, RA Toledo, C Mian, MJ Bugalho, N Wohllk, O Kollyukh, LC Canu, P Loli, SR Bergmann, JB Costa, O Makay, A Patocs, M Pfeifer, NS Shah, T Cuny, M. Brauckhoff, B. Bausch, E von Dobschuetz, C. Letizia, M Barczynski, MK Alevizaki, M. Czetwertyńska, MU Ugurlu, G Valk, JT Plukker, P Sartorato, DR Siqueira, M. Barontini, Małgorzata Szperl, B. Jarząb, HH Verbeek, T Zelinka, P Vlcek, SP Toledo, FL Coutinho, M. Mannelli, M Recasens, L Demarquet, L Petramala, S Yaremchuk, D. Zabolotny, F. Schiavi, G. Opocher, K Racz, Andrzej Januszewicz, G Weryha, JF Henry, T Brue, B Conte-Devolx, C. Eng, HP. Neumann: Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. Lancet, Oncology, 2014, 15 (6) 648-655,
    IF=24.690; MNiSW=50

  5. 5. Tanja Dekkers, Aleksander Prejbisz, Leo J. Schultze Kool, Hans JMM Groenewoud, Marieke Velema, Wilko Spiering, Sylwia Kołodziejczyk-Kruk, Mark Arntz, Jacek Kądziela, Johannes F. Langenhuijsen, Michiel N. Kerstens, Anton H. van den Meiracker, Bert-Jan van den Born, Fred CGJ. Sweep, Ad RMM. Hermus, Andrzej Januszewicz, Alike F. Ligthart-Naber, Peter Makai, Gert-Jan Van der Wilt, Jacques WM. Lenders, Jaap Deinum: Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial. Lancet, Diabetes and Endocrinology, 2016, 4 (9) 739-746
    IF=19.742; MNiSW=50

  6. 6. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Spinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM, the ENGAGE AF-TIMI 48 Investigators.: Edoxaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med. 2013; 369(22):2093-2104.
    IF=54,420; MNiSW=50

  7. 7. Haller H, Ito S, Izzo JL,Jr, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G, ROADMAP Trial Investigators.: Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med. 2011; 364(10): 907-917.
    IF=53.298; MNiSW=40

  8. 8. Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, Forman S, Ruzyllo W, Maggioni AP, White H, Sadowski Z, Carvalho AC, Rankin JM, Renkin JP, Steg PG, Mascette AM, Sopko G, Pfisterer ME, Leor J, Fridrich V, Mark DB, Knatterud GL, Occluded Artery Trial Investigators.: Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006; 355(23): 2395-2407.
    IF=51.296; MNiSW=30

  9. 9. Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O'Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL, the STICH Hypothesis 2 Investigators.: Coronary Bypass Surgery with or without Surgical Ventricular Reconstruction. N Engl J Med. 2009; 360(17):1705-1715.
    IF=47.050; MNiSW=40

  10. 10. Kjekshus J, Apetrei E, Barrios V, Bohm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Janosi A, Kamensky G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J, the CORONA Group.: Rosuvastatin in Older Patients with Systolic Heart Failure. N Engl J Med. 2007; 357: 2248-2261 IF=52.589; MNiSW=40

  11. 11. Melvin D. Lobo, Paul A. Sobotka, Eamon Dolan, Adam Witkowski, Roland E. Schmieder: Central arteriovenous anastomosis and hypertension - Authors' reply Lancet, 2015, 386 (10006) 1821-1822.
    IF=44.002; MNiSW=50

  12. 12. Melvin D. Lobo, P.A. Sobotka, A. Stanton, J.R. Cockcroft, N. Sulke, E. Dolan, M. van der Giet, J. Hoyer, S.S. Furniss, Adam Witkowski, Andrzej Januszewicz, D. Schoors, K. Tsioufis, B.J. Rensing, B. Scott, G.A. Ng, CM Otto, Roland E. Schmieder, ROX CONTROL HTN Investigators: Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial. Lancet, 2015, 385 (9978) 1634-1641.
    IF=44.002; MNiSW=50

  13. 13. Mega J, Braunwald E, Mohanavelu S, Burton P, Poulter R, Misselwitz F, Hricak V, Barnathan E, Bordes P, Witkowski A, Markov V, Oppenheimer L, Gibson C, on behalf of the ATLAS ACS-TIMI 46 study group.: Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. Lancet. 2009; 374(9683): 29-38.
    IF=30.758; MNiSW=40

  14. 14. Neumann HP, Vortmeyer A, Schmidt D, Werner M, Erlic Z, Cascon A, Bausch B, Januszewicz A, Eng C.: Evidence of MEN-2 in the original description of classic pheochromocytoma. N Engl J Med. 2007; 357(13): 1311-1315.
    IF=52.589; MNiSW=40

  15. 15. Nissen SE, Nicholls SJ, Wolski K, Rodes-Cabau J, Cannon CP, Deanfield JE, Despres JP, Kastelein JJ, Steinhubl SR, Kapadia S, Yasin M, Ruzyllo W, Gaudin C, Job B, Hu B, Bhatt DL, Lincoff AM, Tuzcu EM, STRADIVARIUS Investigators.: Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. JAMA. 2008; 299(13): 1547-1560.
    IF=31.718; MNiSW=40

  16. 16. Nissen SE, Tardif JC, Nicholls SJ, Revkin JH, Shear CL, Duggan WT, Ruzyllo W, Bachinsky WB, Lasala GP, Tuzcu EM, ILLUSTRATE Investigators.: Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med. 2007; 356(13): 1304-1316. IF=52.589; MNiSW=40

  17. 17. Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, Dalby AJ, McGuire DK, Leiva-Pons JL, Parkhomenko A, Gottlieb S, Topacio GO, Hamm C, Pavlides G, Goudev AR, Oto A, Tseng CD, Merkely B, Gasparovic V, Corbalan R, Cinteza M, McLendon RC, Winters KJ, Brown EB, Lokhnygina Y, Aylward PE, Huber K, Hochman JS, Ohman EM, for the TRILOGY ACS Investigators.: Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization. N Engl J Med. 2012; 367(14): 1297-1309.
    IF=51.658; MNiSW=50

  18. 18. Schiavi F., Boedeker C., Bausch B., Pęczkowska M., Fuentes Gomez C., Strassburg T., Pawlu C., Buchta M., Salzman M., Hoffman M., Berlis A., Brink I., Cybulla M., Muresan M., Walter M., Forrer F., Valimaki M., Kawecki A., Szutkowski A., Schipper J., Walz M., Pigny P., Bauters C., Willet-Brozick J., Baysal B., Januszewicz A., Eng C., Opocher G., Neumann H.: Predictors and Prevalance of Paraganglioma Syndrome Associated With Mutations of the SDHC Gene. JAMA, 2005; 294 (16): 2057-2063.
    IF=23.494; MNiI=24

  19. 19. Steg PG, Mehta SR, Pollack CV,Jr, Bode C, Cohen M, French WJ, Hoekstra J, Rao SV, Ruzyllo W, Ruiz-Nodar JM, Sabate M, Widimsky P, Kiss RG, Estrada JL, Hod H, Kerkar P, Guneri S, Sezer M, Ruda M, Nicolau JC, Cavallini C, Ebrahim I, Petrov I, Kim JH, Jeong MH, Lopez GA, Laanmets P, Kovar F, Gaudin C, Fanouillere KC, Minini P, Hoffman EB, Moryusef A, Wiviott SD, Sabatine MS.: Anticoagulation With Otamixaban and Ischemic Events in Non-ST-Segment Elevation Acute Coronary Syndromes: The TAO Randomized Clinical Trial. JAMA. 2013; 310(11): 1145-1155.
    IF=30.387; MNiSW=50

  20. 20. Teerlink JR, Metra M, Felker GM, Ponikowski P, Voors AA, Weatherley BD, Marmor A, Katz A, Grzybowski J, Unemori E, Teichman SL, Cotter G.: Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet. 2009; 373(9673): 1429-1439.
    IF=30.758; MNiSW=40

  21. 21. Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, Jennings LH, Ambrosio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, Huber K, Hudson MP, Jiang L, Jukema JW, Lewis BS, Lincoff AM, Montalescot G, Nicolau JC, Ogawa H, Pfisterer M, Prieto JC, Ruzyllo W, Sinnaeve PR, Storey RF, Valgimigli M, Whellan DJ, Widimsky P, Strony J, Harrington RA, Mahaffey KW, for the TRACER Investigators.: Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes. N Engl J Med. 2012; 366(1): 20-33.
    IF=51.658; MNiSW=50

  22. 22. Udell JA, Zawi R ,Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Cannon CP:  Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013, 310 (16): 1711-1720.
    IF=30.387; MNiSW=50

  23. 23. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O'Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL, STICH Investigators.: Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011; 364(17): 1607-1616.
    IF=53.298; MNiSW=40

  24. 24. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM, TRITON-TIMI 38 Investigators.: Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007; 357(20): 2001-2015.
    IF=52.589; MNiSW=40

  25. 25. Wiviott SD, White HD, Ohman EM, Fox KA, Armstrong PW, Prabhakaran D, Hafley G, Lokhnygina Y, Boden WE, Hamm C, Clemmensen P, Nicolau JC, Menozzi A, Ruzyllo W, Widimsky P, Oto A, Leiva-Pons J, Pavlides G, Winters KJ, Roe MT, Bhatt DL.: Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet. 2013; 382(9892): 605-613.
    IF=39.207; MNiSW=50